|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-12-16
|
|
pubmed:abstractText |
Systematic surveillance for resistant malaria shows high level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine (SP) across eastern and southern parts of Africa. This study assessed in vivo SP efficacy after two years of use as an interim first-line drug in Tanzania, and determined the rates of treatment failures obtained after 14 and 28 days of follow-up.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-10450419,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-10450423,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-11675058,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-11937421,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-12429425,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-12641400,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-14580966,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-14757706,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-15504852,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-15642957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16297234-16222009
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1475-2875
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
55
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16297234-Animals,
pubmed-meshheading:16297234-Antigens, Protozoan,
pubmed-meshheading:16297234-Antimalarials,
pubmed-meshheading:16297234-Body Temperature,
pubmed-meshheading:16297234-Child, Preschool,
pubmed-meshheading:16297234-Drug Combinations,
pubmed-meshheading:16297234-Drug Evaluation,
pubmed-meshheading:16297234-Drug Therapy, Combination,
pubmed-meshheading:16297234-Genotype,
pubmed-meshheading:16297234-Health Policy,
pubmed-meshheading:16297234-Hemoglobins,
pubmed-meshheading:16297234-Humans,
pubmed-meshheading:16297234-Infant,
pubmed-meshheading:16297234-Malaria, Falciparum,
pubmed-meshheading:16297234-Parasitemia,
pubmed-meshheading:16297234-Plasmodium falciparum,
pubmed-meshheading:16297234-Protozoan Proteins,
pubmed-meshheading:16297234-Pyrimethamine,
pubmed-meshheading:16297234-Sulfadoxine,
pubmed-meshheading:16297234-Tanzania,
pubmed-meshheading:16297234-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies.
|
|
pubmed:affiliation |
Ifakara Health Research and Development Centre, PO Box 53, Ifakara, Tanzania. kefas.mugittu@unibas.ch
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
